The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.

The biggest differences between the two treatment options were major bleeding events and all-cause mortality. There was no significant difference when it came to stroke risk. 

Access to cannabis is skyrocketing across the United States, but much more research is still needed on its long-term side effects. 

Programs managed by H-E-B, Kroger, Mark Cuban Cost Plus Drug Company and Walmart appear to offer the most options for CVD patients. When it comes to AFib and heart failure, however, researchers believe the choices could be improved. 

It could cost more than $1 million just to avoid a single heart attack, stroke or cardiovascular death, researchers wrote. 

The FDA found that the seeds are actually yellow oleander, a poisonous plant known to contain cardiac glycosides.

The study’s authors examined data from more than 15,000 patients who had their first intracerebral hemorrhage from January 2003 to December 2021

Medicare enrollees paid a total of $3.4 billion in out-of-pocket costs for these drugs in 2022 alone, according to new data shared by the White House.